Durvalumab Consolidation In Patients With Stage Iii Non-Resecable Nsclc With Driver Genomic Alterations
M. Riudavets Melia,E. Auclin, M. A. Mosteiro Lamas,N. Dempsey, M. Majem, R. Lobefaro,R. Lopez Castro,J. Bosch Barrera,S. Pilotto, E. Escalera Martin,M. Tagliamento,J. Mosquera Martinez,G. Zalcman,E. Nadal,G. Lopes, D. Signorelli,M. R. Garcia Campelo, B. Besse, D. Planchard,L. Mezquita ANNALS OF ONCOLOGY（2021）
AI 理解论文
溯源树
样例
